comparemela.com

Neil Fleshner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

Phase 3 SPLASH study of 177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 December.

United statesUnited kingdomNew jerseyEli lillyNeil fleshnerDaniel pearlsteinKim chiMark kinarneyExchange commissionCompany lillyLantheus holdings incBiopharma global incAmerican cancer societyLantheus holdingsMedical oncologistNew drug application

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in

Phase 3 SPLASH study of177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival (rPFS)

United statesUnited kingdomNew jerseyMark kinarneyKim chiEli lillyDaniel pearlsteinNeil fleshnerExchange commissionBiopharma global incLantheus holdings incCompany lillyAmerican cancer societyLantheus holdingsMedical oncologistNew drug application

Point Biopharma insiders to reap millions from Lilly deal – Inside INdiana Business

Point Biopharma insiders to reap millions from Lilly deal – Inside INdiana Business
insideindianabusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insideindianabusiness.com Daily Mail and Mail on Sunday newspapers.

United statesRajesh malikRobin hallettNeil fleshnerGerry hogueJoe mccannAllan silberDavid lubnerEli lillyDavid ricksJohn russellJonathan ross goodmanYael margolinTherapeutics acquisition corpBlackrock incGuidant corp

Point Biopharma insiders to reap millions from Lilly deal – Indianapolis Business Journal

Top executives and directors of Indianapolis-based Point Biopharma Global Inc. could rake in an eye-popping $212 million from their deal to sell the company to drugmaker Eli Lilly and Co.

United statesAllan silberEli lillyRobin hallettDavid lubnerRajesh malikNeil fleshnerGerry hogueYael margolinJonathan ross goodmanJoe mccannDavid ricksBoston scientificPoint biopharma global incEndocyte incGuidant corp

FDA Grants Fast Track Designation to New Prostate Cancer Treatment

The makers of a new treatment for metastatic, castration-resistant prostate cancer are working to bring it to patients “as quickly as possible.”

Neil fleshnerDrug administrationLantheus holdingsFast trackJean claude provostProstate cancer

vimarsana © 2020. All Rights Reserved.